Hoth Therapeutics Allocates $1M to Bitcoin Amid Rising Institutional Adoption
In an effort to take advantage of Bitcoin’s potential as a store of wealth and protection against inflation, Hoth Therapeutics, a biopharmaceutical business in the trial stage, has allocated up to $1 million in the cryptocurrency. In light of the increasing interest in Bitcoin after Donald Trump’s reelection as president.